I went off the official path and still landed on a Windows install I’d recommend.

Background Disease-modifying therapies (DMTs) for Alzheimer’s disease (AD) have early evidence of efficacy. Widespread delivery of DMTs will require major service reconfiguration. Treatment pathways ...

Abstract: The booming development of deep learning applications and services heavily relies on large deep learning models and massive data in the cloud. However, cloud-based deep learning encounters ...

Today, October 14, 2025, is the day Windows 10 enters its End of Life phase, which means Microsoft will no longer officially support the operating system - which means it'll no longer get new features ...

Amyloid-targeted monoclonal antibodies are the first disease-modifying therapies (DMTs) approved for Alzhemier’s disease (AD). Aducanumab received accelerated approval by the FDA but was not fully ...